0001127602-18-034170.txt : 20181121
0001127602-18-034170.hdr.sgml : 20181121
20181121160409
ACCESSION NUMBER: 0001127602-18-034170
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181119
FILED AS OF DATE: 20181121
DATE AS OF CHANGE: 20181121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Clark James David
CENTRAL INDEX KEY: 0001757584
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 181198225
MAIL ADDRESS:
STREET 1: ONE CVS DRIVE
CITY: WOONSOCKET
STATE: RI
ZIP: 02760
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
3
1
form3.xml
PRIMARY DOCUMENT
X0206
3
2018-11-19
0
0000064803
CVS HEALTH Corp
CVS
0001757584
Clark James David
ONE CVS DRIVE
WOONSOCKET
RI
02895
1
SVP, Cont & Chief Acct Officer
Common Stock
8040.2554
D
Common Stock (restricted)
858
D
Common Stock (restricted)
537
D
Common Stock (restricted)
831
D
Common Stock (restricted)
2214
D
Common Stock (restricted)
274
D
Common Stock (restricted)
2009
D
Common Stock (restricted)
1057
D
Common Stock (restricted)
790
D
Stock Option
45.07
2013-04-02
2019-04-02
Common Stock
1664
D
Stock Option
54.53
2014-04-01
2020-04-01
Common Stock
3030
D
Stock Option
74.29
2015-04-01
2021-04-01
Common Stock
5350
D
Stock Option
102.26
2016-04-01
2022-04-01
Common Stock
6059
D
Stock Option
104.82
2017-04-01
2023-04-01
Common Stock
7044
D
Stock Option
78.05
2018-04-03
2024-04-03
Common Stock
9050
D
Stock Option
62.21
2019-04-01
2025-04-01
Common Stock
7513
D
Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2020.
Consists of Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2010 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in two equal installments on 2/28/2019 and 2/28/2020.
Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/1/2019.
Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 2/28/2021.
Consists of Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2010 Incentive Compensation Plan. Restrictions on remaining RSUs lapse 2/28/2019.
Consists of Restricted Stock Units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 4/1/2022.
Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 4/3/2021.
Consists of Restricted Stock Units awarded pursuant to Issuer's Performance-Based Restricted Stock Unit Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 2/28/2019.
Remaining Options became exercisable in four equal annual installments beginning on 4/2/2013.
Remaining Options became exercisable in four equal annual installments beginning on 4/1/2014.
Remaining Options became exercisable in four equal annual installments beginning on 4/1/2015.
Options became exercisable in four equal annual installments beginning on 4/1/2016.
Options became exercisable in four equal annual installments beginning on 4/1/2017.
Options became exercisable in four equal annual installments beginning on 4/3/2018.
Options become exercisable in four equal annual installments, commencing 4/1/2019.
/s/ James D. Clark
2018-11-20